FDA initiates removal of boxed warnings, requests updated labeling for menopausal hormone therapy
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has started the process of removing boxed warnings from menopausal hormone therapy. As part of this process, the FDA is also requesting that the labeling for these therapies be updated. The move appears to be aimed at revising the safety information associated with menopausal hormone therapy.